Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
BMC Health Services Research|October 26, 2019
A predictive model for non-completion of an intensive specialist obesity service in a public hospital: a case-control studyEvan Atlantis, Fang Lin, Sulak Anandabaskaran, et al.Journal of Clinical Medicine|October 14, 2023
Where Are We and Where to Next?-The Future of Perianal Crohn's Disease ManagementSulak Anandabaskaran, Luke Hanna, Nusrat Iqbal, et al.Journal of Crohn'S & Colitis|November 29, 2025
Real-world evaluation of MRI fistula volume as a radiological biomarker of disease activity in perianal fistulizing Crohn's diseaseEasan Anand, Sulak Anandabaskaran, Theo Pelly, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 9, 2020
Colonic malakoplakia in a dual stem cell and cardiac transplant recipient: A case report and literature reviewThomas Meredith, Nila Dharan, Louise Killen, et al.European Journal of Gastroenterology & Hepatology|March 5, 2026
Tissue penetration of anti-tumour necrosis factor therapy in perianal fistulising Crohn's disease: a proof-of-concept studySulak Anandabaskaran, Zhigang Liu, Luke Hanna, et al.The Lancet. Gastroenterology & Hepatology|March 24, 2022
Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trialsJeroen Geldof, Nusrat Iqbal, Jean-Frédéric LeBlanc, et al.The Lancet. Gastroenterology & Hepatology|February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control studyJames L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.The Lancet. Gastroenterology & Hepatology|September 11, 2022
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyJames L Alexander, Zhigang Liu, Diana Muñoz Sandoval, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 12, 2024
Perianal Fistulizing Crohn's Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized CareLuke N Hanna, Sulak Anandabaskaran, Nusrat Iqbal, et al.Journal of Crohn'S & Colitis|November 9, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or TofacitinibZhigang Liu, James L Alexander, Kai Yee Eng, et al.Pageof 2